Open AccessCan regenerative medicine save Big Pharma’s business model from the patent cliff?
Author(s) -
Alexander Denoon,
Erik Vollebregt
Publication year - 2010
Publication title -
regenerative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.572
H-Index - 63
eISSN - 1746-076X
pISSN - 1746-0751
DOI - 10.2217/rme.10.68
Subject(s) - cliff , regenerative medicine , business , business model , data science , computer science , marketing , geography , archaeology , biology , stem cell , genetics